/Investor DB

Cardinal Partners — Full Portfolio

19 tracked investments · listed companies and verified rows first

aTYR PHARMAatyrpharma.comin𝕏NASDAQ: ATYRMar 2015

aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.

BiotechHealthtechMedical DevicesSan Diego, US

Paul Schimmel(Founder)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)inFrederic Chereau(Executive Officer)

BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)

Board seatPaul SchimmelJohn Clarke· per SEC Form D

Co-investorsEcoR1 CapitalSofinnova VenturesViking GlobalDomain AssociatesDomain PartnersPolaris Partners+2 more

Teladoc Healthteladoc.comin𝕏NYSE: TDOCJul 2016

Teladoc Health operates a virtual care platform connecting patients with care providers for medical care, mental health, and chronic disease management services.

Digital HealthHealthtechMental HealthPurchase, US

Michael King(Executive Officer)inMark Hirschhorn(Executive Officer)inJason Gorevic(Executive Officer, Director)inKevin Williamson(Executive Officer)inAdam Vandervoort(Executive Officer)inDaniel Trencher(Executive Officer)in

Board seatThomas G. McKinley· per SEC Form D

Co-investorsDria VenturesHarmonic Growth PartnersHLM Investment PartnersKleiner PerkinsMcKesson VenturesNew Capital Partners+3 more

Alkermesalkermes.cominNASDAQ: ALKS

Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders.

BiotechHealthtechMedical Devices

Richard F. Pops(Chairman of the Board, former CEO)Joshua Reed(Senior Vice President, Chief Financial Officer)inBlair C. Jackson(President & Chief Executive Officer)inDavid J. Gaffin(Executive Vice President, Chief Legal Officer and Chief Compliance Officer; Secretary)inCraig C. Hopkinson(Executive Vice President, Research and Development and Chief Medical Officer)C. Todd Nichols(Senior Vice President, Chief Commercial Officer)in

PartnerJohn Clarke· led

Co-investorsBain Capital Life SciencesVedanta CapitalHatteras Venture Partners

Alnylam Pharmaceuticalsalnylam.comin𝕏NASDAQ: ALNY

Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.

BiotechDigital HealthMedical DevicesCambridge, US

John Maraganore(Founder)inPhillip Sharp(Founder)David Bartel(Founder)Thomas Tuschl(Founder)Paul Schimmel(Founder)Phillip Zamore(Founder)

Co-investorsARCH Venture PartnersAtlas VentureBlackstone Life SciencesInvivo Capital PartnersAlexandria

Priviahealthpriviahealth.comin𝕏NASDAQ: PRVA

Privia Health operates a network of physician practices organized for value-based care delivery, supporting independent practices and physicians across multiple specialties while maintaining clinical autonomy.

Data & InfrastructureDigital HealthEnterprise SoftwareHealthtechSaaSArlington, US

Jeff Butler(Founder)inParth Mehrotra(CEO)

Verastemverastem.comin𝕏NASDAQ: VSTM

Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients.

BiotechMedical DevicesNeedham, US

Robert WeinbergRICHARD ALDRICH(Director)AMY C. CAVERS(Executive Officer)inCATHY CAREW(Executive Officer)inJONATHAN PACHTER(Executive Officer)inROB GAGNON(Executive Officer)in

PartnerJohn Clarke· led

Co-investorsBessemer Venture PartnersForesite CapitalLightstone VenturesLongwood FundOberland CapitalViking Global+1 more

Cardinal Analytxcardinalanalytx.comMar 2018SEC filingmedium confidence

Palo Alto, US

Linda T. Hand(Executive Officer, Director)Niall O'Cathasaigh(Executive Officer)

BoardKent Marquardt(Director)Thomas McKinley(Director)Mark Smith(Director)Elizabeth Spaulding(Director)

Board seatThomas G. McKinleyJohn Clarke· per SEC Form D · $29.3M raise · filed Apr 2019

Co-investorsStartXKleiner Perkins

Athenahealth Incathenahealth.comin

Cloud-based healthcare platform for clinical workflows

Bob SegertinJonathan S. Bush(Founder)Todd Park(Founder)

Co-investorsAspect VenturesBain Capital Double Impact Fund LPBain Capital Tech OpportunitiesBCIDraper AssociatesHellman & Friedman+8 more

Cureatrcureatr.com

New York, US

Joseph Mayer(Director)inJames Bradley(Director)Bharath Ganesan(Director)Richard Resnick(Executive Officer, Director)

BoardJohn Clarke(Director)inTodd Pietri(Director)in

Co-investorsWindham Capital PartnersActivate Venture Partners

Ivenixivenix.cominSep 2015 · $42M

Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors.

BiotechHealthtechMedical DevicesAmesbury, US

John Sokolowski(Executive Officer)inGeorge W. Gray(Executive Officer)Carolyn Malleck(Executive Officer)inJesse Ambrosina(Executive Officer)

BoardKetan Patel(Director)inJohn K. Clarke(Director)in

Co-investorsF-Prime CapitalSCP Vitalife PartnersECO Fleet HoldingsWuXi Healthcare Ventures

Life Imagelifeimage.comin𝕏acquired by Intelerad

Life Image (now part of Intelerad, a GE HealthCare company) provides technology that connects physicians and moves medical imaging and data across the patient journey.

Digital HealthEnterprise SoftwareHealthtechMedical DevicesNewton, US

Hamid Tabatabaie(Executive Officer, Director, Promoter)in

BoardDavid Jahns(Director)Thomas McKinley(Director)William Cowen(Director)in

Co-investorsLRVHealthMassVenturesGalen Partners

Prealizehealthprealizehealth.comin𝕏

Prealize develops AI and machine learning solutions for healthcare providers and health plans to enable proactive, prediction-driven care rather than reactive treatment.

AI & Machine LearningDigital HealthHealthtechInsurTechStanford, US

BoardDr. Arnold MilsteinDr. Nigam Shah

Prexton Therapeuticsprextontherapeutics.cominacquired by Lundbeck

Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.

BiotechHealthtechMedical DevicesCopenhagen, DK

Co-investorsM VenturesSeroba Life SciencesSunstone CapitalYsios CapitalForbion

Sapphire Digitalsapphire-digital.comin𝕏acquired by Zelis

The page discusses healthcare payment integrity topics such as fraud, waste and abuse detection and reducing improper payments, and references member communications tools for health plans.

Digital HealthFintechHealthtech

Vividion Therapeuticsvividion.cominApr 2019 · $82Macquired by Bayer

Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins.

AI & Machine LearningBiotechDeep TechPrinceton, US

Ben Cravatt(Scientific Founder)Phil Baran(Scientific Founder)Jin-Quan Yu(Scientific Founder)Aleksandra Rizo(President and Chief Executive Officer)in

BoardJohn Park(Executive Officer)John Clarke(Executive Officer, Director)in

Co-investorsARCH Venture PartnersAvoro Capital AdvisorsNextech InvestSoftBank Vision FundAlexandriaALTITUDE LIFE SCIENCE VENTURES+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

3MLundbeckMomentapharmaQpidhealth

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.